Anti-Ulcerant Sucralfate API
According to the World Health Organization (WHO), the number of people around the world suffering from gastrointestinal ulcers continues to increase – alongside a growing awareness and availability of treatment options. These and other marketplace factors are driving a surge in demand for high-quality Anti-Ulcerant, which GTI is working with its customers to meet. Our company is currently investing in research, product development and manufacturing facilities to produce Anti-Ulcerant Sucralfate APIs on a global scale.
Our new state-of-the-art API plant
Gulbrandsen Technologies new GMP-compliant plant is operational and validation batches are now under stability study before full commercial launch in 2023.
Adhering to all local and global regulatory requirements, GTI is the only company in India to have an integrated process of making Sucralfate from KSM to API, which will be distributed globally from this new facility.
Uses & Applications:
Treat ulcers of the upper gastrointestinal tract, peptic ulcer disease
Prevent recurrent ulcers after the ulcer has healed
Relieve or prevent ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs)
Treat gastroesophageal reflux disease (GERD)
Sucralfate: Delivery Mechanisms
Suspension & syrups
Powder sachets and pellets
Chewys and candies
With new strains of dangerous pathogens constantly emerging, safeguarding public health from pandemics such as COVID-19 has become a major focus for governments across the globe. As state-level immunization guidelines drive the increased use of recombinant, subunit and synthetic vaccines, GTI continues to actively invest in our ability to reliably supply high-quality Vaccine Adjuvants to our healthcare customers – ensuring that vaccines are available and affordable for all.
Helping you meet the highest standards of quality and compliance:
Building on our long-standing commitment to quality and safety, GTI’s products will be manufactured in sterile, GMP compliant manufacturing units and filled in an aseptic environment in a cleanroom to prevent contamination. These measures are being put in place to ensure that GTI products are suitable for human use, veterinary vaccines and for use in the blood plasma fractionation industry.
With over three decades of aluminum technology experience, GTI is the only company in India and Asia with the capacity to deliver sterile aluminum adjuvants, including mineral-based adjuvants with aluminum oxyhydroxide and aluminum phosphate gel adjuvants
Vaccine Adjuvants - Uses and applications when added to vaccines
Boost immune response longlasting and strong enough to protect from disease
Optimize demand for antigens used in the industrial production of vaccines
An aluminium hydroxide gel which is a suspension of boehmite-like (aluminum oxyhydroxide) hydrated nano/micron size crystals in loose aggregates.
An aluminium phosphate gel which is a suspension of hydrated amorphous aluminium hydroxyphosphate nano/micro size crystal in loose aggregates.